Blood Pressure Oral Medication Dosage
For most adults with hypertension, initial therapy should begin with either a single first-line agent at low dose (for stage 1 hypertension with BP <150/90 mmHg) or two-drug combination therapy (for stage 2 hypertension with BP ≥20/10 mmHg above target), with thiazide diuretics and calcium channel blockers preferred as first-line choices, particularly in Black patients.
Initial Drug Selection by Patient Population
Non-Black Patients Without Compelling Indications
First-line options include:
- Thiazide/thiazide-like diuretics - Chlorthalidone 12.5-25 mg daily (preferred over hydrochlorothiazide due to longer half-life and proven CVD reduction) 1
- ACE inhibitors - Lisinopril 10 mg daily, Enalapril 5 mg daily, or Ramipril 2.5 mg daily 1
- ARBs - Losartan 25-50 mg daily, Valsartan 80 mg daily, or Candesartan 8 mg daily 1
- Calcium channel blockers - Amlodipine 2.5-5 mg daily 1
The 2017 ACC/AHA guidelines demonstrate that chlorthalidone was superior to amlodipine and lisinopril in preventing heart failure, and ACE inhibitors were less effective than thiazide diuretics and CCBs in preventing stroke 1.
Black Patients
Initial therapy should prioritize:
- Thiazide diuretics - Chlorthalidone 12.5-25 mg daily or hydrochlorothiazide 25 mg daily 1
- Calcium channel blockers - Amlodipine 5 mg daily 1
- Combination therapy - Low-dose ARB + DHP-CCB or DHP-CCB + thiazide-like diuretic 1
ACE inhibitors and ARBs are notably less effective in Black patients for stroke prevention and BP lowering compared to thiazide diuretics and CCBs 1.
Monotherapy vs. Combination Therapy Strategy
Stage 1 Hypertension (130-139/80-89 mmHg)
Start with single-agent therapy at low dose if BP goal is <130/80 mmHg and 10-year ASCVD risk ≥10% 1. Titrate dosage and add sequential agents as needed 1.
Specific low-dose starting regimens:
- Chlorthalidone 12.5 mg daily 1
- Lisinopril 10 mg daily (goal dose 20-40 mg daily) 1
- Amlodipine 2.5-5 mg daily 1
- Losartan 25-50 mg daily (goal dose 50-100 mg daily) 1
Stage 2 Hypertension (≥140/90 mmHg or ≥20/10 mmHg above target)
Initiate two first-line agents from different classes, either as separate agents or fixed-dose combination 1. This approach achieves faster BP control and may improve adherence 1.
Preferred two-drug combinations:
- ACE inhibitor/ARB + thiazide diuretic 1
- ACE inhibitor/ARB + calcium channel blocker 1
- Calcium channel blocker + thiazide diuretic 1
Do not combine ACE inhibitors with ARBs - this increases risk of hyperkalemia and renal dysfunction without additional benefit 1.
Dose Titration Algorithm
Step 1: Initial Low-Dose Therapy
Start at the lower end of dosing ranges to minimize adverse effects 1:
- Chlorthalidone 12.5 mg daily
- Lisinopril 10 mg daily
- Amlodipine 2.5-5 mg daily
- Losartan 25-50 mg daily
Step 2: Increase to Full Dose
If BP remains uncontrolled after 2-4 weeks, increase to full therapeutic doses 1:
- Chlorthalidone 25 mg daily
- Lisinopril 20-40 mg daily
- Amlodipine 10 mg daily
- Losartan 100 mg daily
Step 3: Add Second Agent
Add a thiazide-like diuretic if not already included, or add a third drug class from the primary agents 1.
Step 4: Resistant Hypertension (Fourth-Line)
Add spironolactone 12.5-25 mg daily (maximum 25-50 mg daily) as the preferred fourth agent 1. If not tolerated, consider amiloride, doxazosin, eplerenone, clonidine, or beta-blocker 1.
Special Populations and Compelling Indications
Chronic Kidney Disease
ACE inhibitors or ARBs are preferred for patients with CKD and proteinuria 1:
- Benazepril 10 mg daily (goal 20-40 mg daily) 1
- Lisinopril 10 mg daily (goal 20-40 mg daily) 1
- Losartan 25-50 mg daily (goal 25-100 mg daily) 1
- Valsartan 80-160 mg daily (goal 80-320 mg daily) 1
Target BP <130/80 mmHg 1.
Diabetes Mellitus
All first-line classes are equally effective (thiazide diuretics, ACE inhibitors, ARBs, CCBs) 1. ACE inhibitors or ARBs may be considered if albuminuria is present 1. Target BP <130/80 mmHg 1.
Heart Failure with Reduced Ejection Fraction
Beta-blockers are indicated in addition to ACE inhibitors/ARBs 1:
- Carvedilol 3.125 mg twice daily (goal 25 mg twice daily) 1
- Metoprolol succinate 12.5-25 mg daily (goal 200 mg daily) 1
- Bisoprolol 1.25 mg daily (goal 10 mg daily) 1
Ischemic Heart Disease
Beta-blockers are preferred unless contraindicated 1:
- Metoprolol succinate 50 mg daily (goal 50-200 mg daily) 1
- Carvedilol 12.5 mg twice daily (goal 12.5-50 mg twice daily) 1
Avoid abrupt cessation of beta-blockers 1.
Agents to Avoid as First-Line
Beta-blockers are not recommended as first-line therapy unless compelling indications exist (IHD, HF), as they are less effective than CCBs and thiazide diuretics for stroke prevention 1.
Alpha-blockers (doxazosin 1-16 mg daily, prazosin 2-20 mg twice daily) are less effective for CVD prevention than other first-line agents and associated with orthostatic hypotension 1.
Direct renin inhibitors (aliskiren 150-300 mg daily) should not be combined with ACE inhibitors or ARBs due to increased hyperkalemia and renal dysfunction risk 1.
Key Monitoring Parameters
- Reassess BP within 1 month after initiating therapy for stage 1 or stage 2 hypertension 1
- Monitor electrolytes when using thiazide diuretics (risk of hyponatremia, hypokalemia) 1
- Monitor potassium and creatinine when using ACE inhibitors, ARBs, or aldosterone antagonists, especially in CKD 1
- Target achievement within 3 months of treatment initiation 1
Common Pitfalls
Avoid underdosing - Many physicians use lower than recommended doses, reducing efficacy 1. Titrate to goal doses shown in clinical trials.
Avoid ACE inhibitor + ARB combinations - This increases adverse effects without additional benefit 1.
Monitor for ACE inhibitor cough (occurs in up to 10-20% of patients) - If persistent and troublesome, switch to ARB rather than discontinuing RAAS blockade entirely 1.
Avoid beta-blockers in reactive airway disease - Use cardioselective agents (metoprolol, bisoprolol) if beta-blockade is required 1.